N‐acetylation genotype and risk of severe reactions to sulphonamides in AIDS patients [letter]Claudine Deloménie, J M Dupret, Deborah Grant et al.|British Journal of Clinical Pharmacology|1994Cited by 37
Human Immunodeficiency Virus Type 1 Group O Infection in France: Clinical Features and Immunovirological Response to AntiretroviralsGuillemette Unal, O. Lesens, Élodie Alessandri-Gradt et al.|Clinical Infectious Diseases|2017Cited by 7
Doravirine plus lamivudine two-drug regimen as maintenance antiretroviral therapy in people living with HIV: a French observational studyPascale Perfezou, Isabelle Fabre, Romain Palich et al.|Journal of Antimicrobial Chemotherapy|2023Cited by 7
Hepatitis B Surface Antibody Clearance After Vaccination in People With HIVAxel Ursenbach, François Bissuel, François Séverac et al.|Open Forum Infectious Diseases|2025Cited by 1
Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimenLise Cuzin, Marine Morrier, Clotilde Allavena et al.|Université Pierre et Marie CURIE (UPMC)|2017Cited by 0